Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1995-06-05
1998-06-09
Chambers, Jasemine C.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
4353201, 435375, 435 691, 4351723, 935 62, 935 70, 514 44, C12N 500, C12N 1509, C12N 1579, A61K 4800
Patent
active
057629269
ABSTRACT:
Methods of genetically modifying donor cells by gene transfer for grafting into the central nervous system to treat defective, diseased or damaged cells are disclosed. The modified donor cells produce functional molecules that effect the recovery or improved function of cells in the CNS. Methods and vectors for carrying out gene transfer and grafting are described.
REFERENCES:
patent: 4497796 (1985-02-01), Salser et al.
patent: 5082670 (1992-01-01), Gage et al.
patent: 5399346 (1995-03-01), Anderson
Khillan, J.S. (1986) Developmental and tissue-specific expression directed by the .alpha..sub.2 type 1 collagen promoter in transgenic ice, Proc. Natl. Acad. Sci. 83:725-729.
Gage et al., Neuroscience S590 Suppl 22:1766.
Marion et al. (1990) Brain Research, 519:133-143.
Friedmann, T. (1989) Implantation of genetically modified cells into the rat brain an approach to restoration of CNA functions, Gene Transfer and Gene Therapy, pp. 409-416.
Rosenberg, K. et al. (1987) Introduction of new genes into adult rat brain via grafted cells, Soc. Ns Abstracts 13:515 141.15.
Eldrup-Jorgensen, J. et al., Antiplatelet therapy and vascular grafts, Arch. Surg., 121:778-781.
Brems, J. et al. (1986) A five-year experience with the bovine heterograft for vascular access, Arch. Surg., 121:941-944.
Kojima, Y. et al. (1987) Xenografts and artificial pancreas transplantation, Transplantation Proceedings 19:981-983.
Reach, G. (1984) Bioartificial pancreas, present state and future prospects, Biomed. Biochem. Acta 43:569-576.
Brynitz, S. et al. (1988) Post-mortem allogeneic vein for graft as vascular access in chronic haemodialysis, The Lancet 900-901.
Bjorklund and Stenevi, eds. (1985) Neural grafting in the mammalian CNS, Das, Freed Ch. 4, pp. 31-40 at pp. 35-36, Table III.
Lim and Sun (1985) Science 210:908-910.
R. Selden et al. Science 236:714.
R. Handschumacher, Drugs used for immunosuppression, Chapter 53 at pp. 1264-1276, at p. 1270.
Mathiesen (1989) Prolonged survival and vascularization of xenografted human glioblastoma cells in the central nervous system of cyclosporin a-treated rats, Cancer Lett. 44(2):151-156.
S. Boularand et al., Complete coding sequence of human tryptophan hydroxylase, Nucleic Acids Research 18(14):4257.
B. Koch et al. (1991) PNAS 88:8754.
Wan-I Li et al., Synthesis and secretion of immunoreactive methionine-enkephalin from rabbit reproductive tissues in vivo and in vitro, Biology of Reproduction 45:691.
G. Bruneau et al., Preparation of a human dopa decarboxylase cDNA probe by PCR and its assignment to chromosome 7, Annales de Genetique 33(4):208.
Negro et al. (1991) Cloning and expression of human ciliary neurotrophic factor, Eur. J. Biochem. 201:289.
P. Isackson et al., Comparison of mammalian, chicken, and Xenopus brain-derived neurotrophic factor coding sequences, FEBS Letters 285(2):260.
Maisonpierre et al. (1991) Genomics 10(3):558-568.
J. Hebert et al. (1990) Isolation of cDNAs encoding four mouse FGF family members and characterization of their expression patterns during embryogenesis, Developmental Biology 138:454.
Rosenstein, J.M. (1987) Neocortical transplants in the mammalian brain lack a blood-brain barrier to macromolecules, Science 235:772-774.
Bjorklund, et al. (1985) Neural grafting in the mammalian CNS, Elsevier, Amsterdam p. 709.
Sladek et al. (1984) Neural transplants: development and function, Plenum Press, New York.
Marsden (1986) Movement disorders and the basal ganglia, Trends Neurosci. 9:512-515.
Vinken et al., Eds. (1986) Drug-induced movement disorders (tardive dyskinesia and dopa-induced dyskinesia) Handbook of Clinical Neurology, Elsevier, Amsterdam (Tanner, author) 5:185-204.
Backlund et al. (1985) Transplantation of adrenal medullary tissue to striatum in parkinsonism, J. Neurosurg, 62:169-173.
Madrazo et al. (1987) Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's Disease, New Eng. J. Med. 316:831-834.
Bjorklund et al. (1986) Neural grafting in animal models of neurodegenerative diseases, Ann. N.Y. Acad. Sci. 457:53-81.
Dunnett et al. (1983) Dopamine-rich transplants in experimental parkinsonism, Trends Neurosci. 6:266-270.
Gusella et al. (1983) A polymorphic DNA marker genetically linked to Huntington's disease, Nature 306:234-238.
Delabar et al. (1987) B amyloid gene duplication in alzheimer's disease and karyotypically normal down syndrome, Science New York 235:1390-1392.
Goldgaber et al. (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of alzheimer's disease, Science N.Y. 235:877-880.
St. George-Hyslop et al. (1987) The genetic defect causing familia disease maps on chromosome 21, Science N.Y. 235:885-890.
Tanzi et al. (1987) Amyloid B protein gene: cDNA, mRNA distribution, and genetic linkage near the alzheimer locus, Science N.Y. 235:880-884.
Baron et al. (1987) Genetic linkage between x-chromosome markers and bipolar affective illness, Nature 326:289-292.
Sherrington et al. (1988) Localization of a susceptibility locus for schizophrenia on chromosome 5, Nature 336:164-167.
Anderson (1984) Prospects for human gene therapy, Science 226:401-409.
Freedman et al. (1972) Gene therapy for human genetic disease? Science 175:949-955.
Friedmann (1983) Gene therapy: fact and fiction in biology's new approaches to disease, Cold Spring Harbor Laboratory, New York.
Costantini et al. (1986) Correction of murine-b-thalassemia by gene transfer into the germ line, Science 233:1192-1194.
Mason et al. (1986) The hypogonadal mouse: reproductive functions restored by gene therapy, Science 234:1372-1378.
Readhead et al. (1987) Expression of a myelin basic protein gene in transgenic shiverer mice: correction of the dysmyelinating phenotype, Cell 48:701-712.
Gilboa et al. (1986) Transfer and expression of cloned genes using retroviral vectors, Bio Techniques 4:504-512.
Shimotohno et al. (1981) Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus, Cell 26:67-77.
Wei et al. (1981) Construction and isolation of a transmissible retrovirus containing the src gene of harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type I, J. Virol. 39:935-944.
Tabin et al. (1982) Adaptation of a retrovirus as a eucaryotic vector transmitting the herpes simplex virus thymidine kinase gene, Cell Biol. 2:426-436.
Willis et al. (1984) Partial phenotypic correction of human lesch-nyhan (hypoxanthine-guanine phosphoribosyltransferase-deficient) lymphoblasts with a transmissible retroviral vector, J. Biol. Chem. 259:7842-7849.
Kantoff et al. (1986) Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer, Proc. Natl. Acad. Sci. USA 83:6563-6567.
McIvor et al. (1987) Human purine nucleoside phosphorylase and adenosine deaminase: gene transfer into cultured cells and murine hematopoietic stem cells by using recombinant amphotropic Retroviruses, Molec. Cell Biol. 7:838-846.
Soriano et al. (1986) Tissue-specific and ectopic expression of genes introduced into transgenic mice by retroviruses, Science 234:1409-1413.
Wolff et al. (1987) Expression of retrovirally transduced genes in primary cultures of adult rat hepatocytes, Proc. Natl. Acad. Sci. USA 84:3344-3348.
Khoury et al. (1983) Enhancer Elements, Cell 33:313-314.
Serfling et al. (1985) Enhancers and eukaryotic gene transcription, Trends Genet. 1:224-230.
Wolff and Friedmann (1988) Approaches to gene therapy disorders of purine metabolism, Rheumatic Dis. Clin. N. Amer. 14(2):459-477.
Eglitis and Anderson (1988) Retroviral vectors for introduction of genes into mammalian cells, BioTechniques, 6:608-614.
Joyner et al. (1983) Retrovirus transfer of a bacterial gene into mouse haematopoietic progenitor cells, Nature 305:556-558.
Miller et al. (1984) Expression of a retrovirus encoding human hprt in mice, Science 225:630-632.
Williams et al. (1984) Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse, Nature 310:476-480.
Selden et al. (
Friedmann Theodore
Gage Fred H.
Kawaja Michael D.
Ray Jasodhara
Rosenberg Michael B.
Chambers Jasemine C.
Hauda Karen M.
The Regents of the University of California
LandOfFree
Method of grafting genetically modified cells to treat defects, does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of grafting genetically modified cells to treat defects, , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of grafting genetically modified cells to treat defects, will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2195847